Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02633306 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation for Facial Pain

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT02633306: Completed NA study, sponsored by University of Minnesota.

NCT02633306 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02633306, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Complex oro-facial pain is a poorly diagnosed and poorly treated cause of significant suffering and disability. This study will explore the ability of fMRI to identify patients with complex oro-facial pain who respond to transcranial magnetic stimulation therapy. Specific Aims: 1. To establish baseline patterns of MRI in patients with chronic oro-facial pain without a definitive etiologic diagnosis. 2. To estimate the rate of treatment success of transcranial stimulation of the primary motor cortex (M1) in these patients. 3. To identify post-treatment MRI patterns that are associated with treatment success.

Primary Outcome

Participants are asked to rate pain on a100 mm visual analogue scale with 0 representing no pain and 100 representing worst possible pain. The mean difference from baseline to 7 days post-treatment is recorded.

Interventions

  • DEVICE transcranial magnetic stimulation

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2016-08-01
Est. Completion 2019-08-30
Phase NA
University of Minnesota

966 total trials

What the finished NCT02633306 record still lists

NCT02633306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.

NCT02633306 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02633306 about?

NCT02633306 is a clinical study titled "Transcranial Magnetic Stimulation for Facial Pain". Complex oro-facial pain is a poorly diagnosed and poorly treated cause of significant suffering and disability. This study will explore the ability of fMRI to identify patients with complex oro-facial pain who respond to transcranial magnetic stimulation therapy. Specific Aims: 1. To establish bas...

What is the current status of trial NCT02633306?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2016-08-01. Estimated completion is 2019-08-30.

What interventions are being tested in trial NCT02633306?

The interventions under investigation include: transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT02633306?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02633306's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02633306, the US trial registry maintained by the National Library of Medicine. NCT02633306 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.